SAGE THERAPEUTICS

Serial Number 88466485
Registration 6365035
700

Registration Progress

Application Filed
Jun 10, 2019
Under Examination
Jun 2, 2020
Approved for Publication
Apr 7, 2020
Published for Opposition
Apr 7, 2020
Registered
May 25, 2021

Basic Information

Serial Number
88466485
Registration Number
6365035
Filing Date
June 10, 2019
Registration Date
May 25, 2021
Published for Opposition
April 7, 2020
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
May 25, 2021
Registration
Registered
Classes
005

Rights Holder

Sage Therapeutics, Inc.

03
Address
55 Cambridge Parkway
Suite 401
Cambridge, MA 02142

Ownership History

Sage Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Sage Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Sage Therapeutics, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Steven A. Abreu

USPTO Deadlines

Next Deadline
685 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-05-25)
Due Date
May 25, 2027
Grace Period Ends
November 25, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

43 events
Date Code Type Description
Mar 25, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 25, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 25, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 25, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 25, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 25, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 17, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 16, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 27, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 26, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Mar 26, 2021 EX2G S SOU EXTENSION 2 GRANTED
Mar 25, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 11, 2021 EXT2 S SOU EXTENSION 2 FILED
Mar 11, 2021 IUAF S USE AMENDMENT FILED
Mar 11, 2021 EISU I TEAS STATEMENT OF USE RECEIVED
Mar 11, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 4, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 2, 2020 EX1G S SOU EXTENSION 1 GRANTED
Dec 2, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 2, 2020 EXT1 S SOU EXTENSION 1 FILED
Jun 2, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 7, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2020 PUBO A PUBLISHED FOR OPPOSITION
Mar 18, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 25, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 25, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 25, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 25, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 25, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 25, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 25, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 10, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 30, 2019 GNRT F NON-FINAL ACTION E-MAILED
Aug 30, 2019 CNRT R NON-FINAL ACTION WRITTEN
Aug 30, 2019 DOCK D ASSIGNED TO EXAMINER
Aug 30, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 16, 2019 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Jul 16, 2019 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 25, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 22, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 13, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
house mark for pharmaceutical preparations
First Use Anywhere: Dec 20, 2019
First Use in Commerce: Dec 20, 2019

Additional Information

Design Mark
The mark consists of three intersecting curved shapes to the left of the words "Sage Therapeutics", where "Sage" appears above the word "Therapeutics".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"